On demand pharmacology CE/CME
About this course
This course provides 15 contact hours of pharmacy CE and (1.5 CEU) of live AAFP/ AMA PRA Category 1 Credit™, ACPE and pharmacology CE/CME credit.
Price $250
Recorded Live on June 2-4 2026 in Las Vegas Nevada
Term of Approval is from 06/02/2026 to 06/02/2027
Educational information
Designed for convenient viewing on a smartphone or computer. Lessons include recorded presentations, course materials, assessment, and completion documentation.
| Session |
|---|
|
2026-06-02 From Guidelines to Bedside: Modern ACC/AHA Strategies for Hypertension and Dyslipidemia Management
Tuesday, June 2, 2026 Speaker: Dr. Joseph Saseen Credit hours: 5 ACPE UAN: 0741-0000-26-012-H01-P Learning objectives
|
|
2026-06-03 Obesity, Drug Interactions, Jeopardy
Wednesday, June 3, 2026 Speaker: Dr. Christopher M. Bland Credit hours: 5 ACPE UAN: 0741-0000-26-013-H01-P Learning objectivesOvercoming Obesity: Update on Current and Future Pharmacotherapy Options 1. Describe appropriate patients who may benefit from obesity pharmacotherapy. 2. Evaluate common obesity medications with potential therapeutic uses as well as common and severe adverse reactions. 3. Identify potential future obesity medication therapies that may offer advantages over current FDA-approved agents. Drug Interactions: 4. Identify common drug interaction mechanisms including cytochrome P450 enzymes. 5. Identify relevant clinical drug interactions for common medications. 6. Delineate assessment and management strategies for common interactions. Obesity and Drug Interactions Jeopardy 7: Identify key laboratory values and parameters for monitoring drug therapy. 8. Describe key characteristics of common drug therapies. 9 Identify clinical pearls from various pharmacotherapy therapies. |
|
2026-06-04 New Drug Update, Osteoporosis, Jeopardy
Thursday, June 4, 2026 Speaker: Dr. Christopher M. Bland Credit hours: 5 ACPE UAN: 0741-0000-26-014-H01-P Learning objectivesNew Drug Update: 1. Describe new drugs approved in the last 12-18 months that have potential to impact clinical practice. 2. Discuss clinical and practical pearls of each new agent where applicable compared to standard therapies. 3. Evaluate each agent's efficacy and safety data to best determine role in therapy. Review of Current Osteoporosis Treatments: 4. Differentiate pharmacotherapy options for the management of osteoporosis. 5. Apply current osteoporosis treatment guidelines to develop individualized treatment plans. 6. Identify strategies to optimize long-term clinical and safety outcomes. New Drug, Osteoporosis Jeopardy 7: Identify key laboratory values and parameters for monitoring drug therapy. 8. Describe key characteristics of common drug therapies. 9 Identify clinical pearls from various pharmacotherapy therapies. |
Associate Dean for Clinical Affairs and Professor · University of Colorado Skaggs School of Pharmacy
A nationally recognized ambulatory-care and cardiovascular-risk-reduction educator with nearly 200 peer-reviewed publications and book chapters.
Clinical Professor · University of Georgia College of Pharmacy
A clinical pharmacy educator and co-founder of Southeastern Research Group Endeavor and TeachMePharm, with a focus on practical infectious-disease pharmacotherapy.
Pharmacists, Nurse Practitioners, Physicians, Physician Assistants, Nurses
The American Academy of Family Physicians (AAFP) has reviewed Providing Better Patient Care and deemed it acceptable for up to 15 Live AAFP Prescribed credit(s). Term of Approval is from June 2, 2026 to June 4, 2026 Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s) toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Osteopathic Association (AOA). Continuing medical education (CME) activities approved for American Academy of Family Physicians (AAFP) credit are recognized by the American Osteopathic Association (AOA) as equivalent to AOA Category 2 credit.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for Prescribed credit from AAFP
CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.
CANADIAN PHARMACISTS:Canadian Council on Continuing Education in Pharmacy (CCCEP)accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE).
CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians
| Description | Price |
|---|---|
| Default 15 Hours | $250 |
Begin today